# Duo Oncology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/duo-oncology

- Industry: Pharmaceuticals
- Headquarters: Pittsburgh, US
- Website: www.duooncology.com
- Total disclosed funding: $4.3M
- Latest round: Seed (Aug 11, 2023)
- Investors on record: 6

## About

Based in Pennsylvania, US, and founded in 2020, Duo Oncology Inc. provides cancer treatment therapies using nanotechnology. The company was co-founded by Sam Rothstein, who is leading the firm as CEO as of 2023. In August 2023, the firm raised USD 3 million in Seed funding led by investor SeedFolio, with participation from other investors BeiGene Ltd., Innovation Works, LifeX Ventures, NuFund Venture Group, and Ulu Ventures.

The business offers Duo’s nanomedicine platform for treating tumors that have already spread. With a novel kind of monotherapy, the company's approach transforms outcomes for patients with pancreatic cancer, bile duct cancer, and recurrent metastatic illness.

The company plans to use the August 2023 funding to expand its development of DUO-207.

## Funding rounds

- Seed, Aug 11, 2023, $1.6M — Ulu Ventures, BeiGene Ltd., Innovation Works, LifeX Ventures, SeedFolio, NuFund Venture Group
- Seed, Mar 31, 2023, $2.7M — Ulu Ventures, BeiGene Ltd., Innovation Works, LifeX Ventures, SeedFolio, NuFund Venture Group

## Investors

- Ulu Ventures (https://capitalatlas.ai/funds/ulu-ventures) — Seed
- BeiGene Ltd. — Seed
- Innovation Works (https://capitalatlas.ai/funds/innovation-works) — Seed
- LifeX Ventures (https://capitalatlas.ai/funds/lifex-ventures) — Seed
- SeedFolio (https://capitalatlas.ai/funds/seedfolio) — Seed
- NuFund Venture Group (https://capitalatlas.ai/funds/nufund-venture-group) — Seed